{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:08:34Z","timestamp":1777874914485,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016200","name":"Augusta University Medical College of Georgia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cjca.2025.08.344","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:18:54Z","timestamp":1756509534000},"page":"2353-2357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease Registries as a National Asset: The Canadian CAPER"],"prefix":"10.1016","volume":"41","author":[{"given":"D. Douglas","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.08.344_bib1","first-page":"2584","article-title":"Development and initial results from the Canadian Cardiac Amyloidosis PyrophosphatE Imaging Registry \u2013 CAPER (Design and Initial Observational Study)","volume":"41","author":"Akincioglu","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.344_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jacc.2011.12.007","article-title":"Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry","volume":"59","author":"Fefer","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.344_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.010546","article-title":"Canadian Multicenter Chronic Total Occlusion Registry: ten-year follow-up results of chronic total occlusion revascularization","volume":"14","author":"Strauss","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.08.344_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cjco.2020.09.002","article-title":"The Canadian contribution to science, techniques, technology, and education in chronic total occlusion percutaneous coronary intervention","volume":"3","author":"Ybarra","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.08.344_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cjco.2022.04.005","article-title":"The Canadian Heart Failure (CAN-HF) Registry: a Canadian multicentre, retrospective study of inpatients with heart failure","volume":"4","author":"Poon","year":"2022","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.08.344_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cjco.2024.09.014","article-title":"The Canadian Heart Failure (CAN-HF) Registry: a Canadian multicentre, retrospective study of outpatients with heart failure","volume":"7","author":"Saveski","year":"2025","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.08.344_bib7","first-page":"441","article-title":"Expanding the impact of a longstanding Canadian cardiac registry through data linkage: challenges and opportunities (Information Systems \/ Data Core for >200 Publications)","volume":"3","author":"Southern","year":"2018","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/j.cjca.2025.08.344_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cjco.2020.11.014","article-title":"The Canadian Pediatric Cardiology Research Network: a model national data-sharing organization to facilitate the study of pediatric heart diseases","volume":"3","author":"Dallaire","year":"2021","journal-title":"CJC Open"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2025.08.344_bib10","article-title":"Association of CMR-derived left ventricular filling pressure with adverse outcomes in a cardiovascular disease referral population: findings from the CIROC registry (abstract)","volume":"27","author":"Khan","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjca.2025.08.344_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.344_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcct.2023.10.004","article-title":"Rationale and design of CONFIRM2 (Quantitive COroNary CT Angiography for Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) study","volume":"18","author":"Van Rosendael","year":"2024","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.cjca.2025.08.344_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cardfail.2023.09.016","article-title":"The Cardiac Amyloidosis Registry Study (CARS): rationale, design and methodology","volume":"30","author":"Stern","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2025.08.344_bib14","series-title":"The world is flat","author":"Friedman","year":"2005"},{"key":"10.1016\/j.cjca.2025.08.344_bib17","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.08.344_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.08.344_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis (NEURO-TTRansform)","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.08.344_bib20","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy (NEURO-TTRansform)","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2025.08.344_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.hrtlng.2021.03.065","article-title":"P010. Evaluation of the safety and efficacy of AKCEA-TTR-Lrx (ION-682884) in patients with transthyretin-mediated amyloid cardiomyopathy: the CARDIO-TTRansform study","volume":"50","author":"Maurer","year":"2021","journal-title":"Heart Lung"},{"key":"10.1016\/j.cjca.2025.08.344_bib22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy (ATTR-ACT)","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.08.344_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy (ATTRibute-CM)","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.08.344_bib24","author":"Adams"},{"key":"10.1016\/j.cjca.2025.08.344_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"HELIOS-B: vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.08.344_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2796.2003.01201.x","article-title":"The evolution of the randomized controlled trial and its role in evidence-based decision making","volume":"254","author":"Devereaux","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.cjca.2025.08.344_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cardfail.2021.08.016","article-title":"The incidence and prevalence of cardiac amyloidosis in a large community-based cohort in Alberta, Canada","volume":"28","author":"Sepehrvand","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2025.08.344_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2025.08.344_bib30","first-page":"2566","article-title":"Factors influencing clinical initiation of tafamidis therapy for transthyretin amyloidosis cardiomyopathy: a Canadian referral center experience","volume":"40","author":"Shahi","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.344_bib31","first-page":"1643","article-title":"Amyloidosis tissue confirmation for tafamidis eligibility using transverse carpal ligament and tenosynovium biopsy","volume":"38","author":"Khayambashi","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.344_bib32","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.08.344_bib33","article-title":"Association between atrial uptake on cardiac scintigraphy with technetium-99m-pyrophosphate labeled bone-seeking tracers and atrial fibrillation","volume":"15","author":"Hussain","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.08.344_bib34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamacardio.2023.2010","article-title":"Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping","volume":"8","author":"Ionannou","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2025.08.344_bib35","article-title":"Study design of the CARDIO-TTRansform cardiac magnetic resonance imaging substudy","volume":"45","author":"Fontana","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:32:32Z","timestamp":1777581152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25010402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0828282X25010402"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.344","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease Registries as a National Asset: The Canadian CAPER","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.357","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}